1. Efficacy of oncometabolic surgery.
| Authors | Location | Design | Operation | CR [n (%)] | PR [n (%)] | CR+PR
[n (%)] |
Sample
size (n) |
Follow-up period (month) |
| CR, complete remission; PR, partial remission; RYTG, Roux-en-Y total gastrectomy; BII, Billroth II; BI, Billroth I; RYGJ, subtotal gastrectomy with Roux-en-Y gastrojejunostomy reconstruction; LLBR, long-limb bypass reconstruction; NA, not available. | ||||||||
| Ho et al. (15) | Taiwan,
China |
Database | RYTG | 178 (30.7) | NA | NA | 579 | NA |
| Wei et al. (17) | China | Retrospective cohort study | RYTG | 13 (46.4) | 7 (25.0) | 20 (71.4) | 28 | 24 |
| BII | 5 (12.8) | 15 (38.5) | 20 (51.3) | 39 | 24 | |||
| Kang et al. (18) | Korea | Retrospective review | RYTG | 4 (23.5) | NA | NA | 17 | 35 |
| BII | 6 (22.2) | NA | NA | 27 | 35 | |||
| BI | 0 (0) | NA | NA | 31 | 35 | |||
| Lee et al. (19) | Korea | Retrospective review | RYTG | 1 (5.6) | 1 (5.6) | 2 (11.2) | 18 | 24 |
| BII | 3 (9.1) | 3 (9.1) | 6 (18.2) | 33 | 24 | |||
| BI | 0 (0) | 0 (0) | 0 (0) | 19 | 24 | |||
| Pak et al. (36) | Korea | Retrospective cohort study | RYTG | NA | NA | 14 (73.7) | 19 | 24 |
| BII | NA | NA | 26 (61.9) | 42 | 24 | |||
| BI | NA | NA | 14 (48.3) | 29 | 24 | |||
| Zhu et al. (37) | China | Retrospective review | RYTG | NA | NA | 57 (90.5) | 63 | 24 |
| BII | NA | NA | 75 (72.8) | 103 | 24 | |||
| BI | NA | NA | 58 (46.0) | 126 | 24 | |||
| Lee et al. (38) | Korea | Unspecified | RYTG | NA | NA | 8 (50.0) | 16 | 12 |
| BII | NA | NA | 11 (20.3) | 54 | 12 | |||
| BI | NA | NA | 18 (15.1) | 119 | 12 | |||
| RYGJ | NA | NA | 8 (20.0) | 40 | 12 | |||
| Kwon et al. (39) | Korea | Retrospective cohort study | BII | NA | NA | 13 (50.0) | 26 | 24 |
| BI | NA | NA | 9 (39.1) | 23 | 24 | |||
| Kim et al. (40) | Korea | Prospective cohort study | LLBR | NA | NA | 9 (30) | 30 | 12 |
| Kim et al. (42) | Korea | Retrospective cohort study | LLBR | 11 (8.5) | 4 (3.1) | 15 (11.5) | 130 | 12 |
| BII | 0 (0) | 1 (1.0) | 1 (1.0) | 96 | 12 | |||
| An et al. (47) | Korea | Prospective cohort study | RYTG | NA | NA | 1 (8.3) | 12 | 12 |
| BII | NA | NA | 1 (6.2) | 16 | 12 | |||
| BI | NA | NA | 0 (0) | 36 | 12 | |||
| Kim et al. (48) | Korea | Cross-sectional study | RYTG | 27 (27.3) | NA | NA | 99 | 33.7 |
| BII | 14 (11.2) | NA | NA | 125 | 33.7 | |||
| BI | 17 (10.6) | NA | NA | 161 | 33.7 | |||
| Wang et al. (49) | Taiwan,
China |
Retrospective cohort study | RYTG | NA | NA | 3 (27.3) | 11 | 45.1 |
| BII | NA | NA | 1 (5.9) | 17 | 125.8 | |||
| BI | NA | NA | 2 (18.2) | 11 | 105.1 | |||
| RYGJ | NA | NA | 3 (10.0) | 30 | 28.9 | |||